Next Article in Journal
Attitudes and Beliefs towards Rotavirus Vaccination in a Sample of Italian Women: A Cross-Sectional Study
Next Article in Special Issue
Anti-S and Anti-N Antibody Responses of COVID-19 Vaccine Recipients
Previous Article in Journal
Identification by Reverse Vaccinology of Three Virulence Factors in Burkholderia cenocepacia That May Represent Ideal Vaccine Antigens
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Vaccines
Volume 11
Issue 6
10.3390/vaccines11061040
vaccines-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Editorial

Safety, Tolerability, and Immunogenicity of COVID-19 Bivalent Vaccination

by
Divyasha Saxena
1,
Lalit Batra
1,* and
Shailendra Kumar Verma
2
1
Center for Predictive Medicine, University of Louisville, Louisville, KY 40202, USA
2
Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, San Diego, CA 92130, USA
*
Author to whom correspondence should be addressed.
Vaccines 2023, 11(6), 1040; https://doi.org/10.3390/vaccines11061040
Submission received: 18 May 2023 / Accepted: 21 May 2023 / Published: 30 May 2023
(This article belongs to the Collection The Safety and Immunogenicity of the Bivalent Omicron-Containing mRNA-1273.214 Booster Vaccine)
Versions Notes

Excerpt

Note: In lieu of an abstract, this is an excerpt from the first page.

The COVID-19 pandemic has triggered unparalleled global disruption [...]

Share and Cite

MDPI and ACS Style

Saxena, D.; Batra, L.; Verma, S.K. Safety, Tolerability, and Immunogenicity of COVID-19 Bivalent Vaccination. Vaccines 2023, 11, 1040. https://doi.org/10.3390/vaccines11061040

AMA Style

Saxena D, Batra L, Verma SK. Safety, Tolerability, and Immunogenicity of COVID-19 Bivalent Vaccination. Vaccines. 2023; 11(6):1040. https://doi.org/10.3390/vaccines11061040

Chicago/Turabian Style

Saxena, Divyasha, Lalit Batra, and Shailendra Kumar Verma. 2023. "Safety, Tolerability, and Immunogenicity of COVID-19 Bivalent Vaccination" Vaccines 11, no. 6: 1040. https://doi.org/10.3390/vaccines11061040

APA Style

Saxena, D., Batra, L., & Verma, S. K. (2023). Safety, Tolerability, and Immunogenicity of COVID-19 Bivalent Vaccination. Vaccines, 11(6), 1040. https://doi.org/10.3390/vaccines11061040

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop